0001209191-19-060277.txt : 20191212 0001209191-19-060277.hdr.sgml : 20191212 20191212182033 ACCESSION NUMBER: 0001209191-19-060277 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191210 FILED AS OF DATE: 20191212 DATE AS OF CHANGE: 20191212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Johnson Craig A CENTRAL INDEX KEY: 0001370348 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38318 FILM NUMBER: 191282904 MAIL ADDRESS: STREET 1: C/O PURE BIOSCIENCE STREET 2: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Odonate Therapeutics, Inc. CENTRAL INDEX KEY: 0001717452 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822493065 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 510 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-200-3830 MAIL ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 510 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Odonate Therapeutics, Inc DATE OF NAME CHANGE: 20171207 FORMER COMPANY: FORMER CONFORMED NAME: Odonate Therapeutics, LLC DATE OF NAME CHANGE: 20170919 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-10 0 0001717452 Odonate Therapeutics, Inc. ODT 0001370348 Johnson Craig A C/O ODONATE THERAPEUTICS, INC. 4747 EXECUTIVE DRIVE, SUITE 510 SAN DIEGO CA 92121 1 0 0 0 Stock Option (Right to Buy) 30.51 2019-12-10 4 A 0 12500 0.00 A 2029-12-10 Common Stock 12500 12500 D The stock options vest and become exercisable as follows: (i) 50% on the date of U.S. Food and Drug Administration ("FDA") approval of tesetaxel; (ii) 25% on the first anniversary of FDA approval of tesetaxel; and (iii) 25% on the second anniversary of FDA approval of tesetaxel. Vesting is subject to the Reporting Person's continued service to the Issuer through each vesting date. /s/ John Lemkey, as attorney-in-fact for Craig Johnson 2019-12-12